Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aukrust

Showing results (311-320 of 1,012) with videos related to

Pageof 102
Sort By:
Journal of Human Genetics|August 30, 2013
Single-nucleotide polymorphisms in Toll-like receptor (TLR)-2, TLR4 and heat shock protein 70 genes and susceptibility to scrub typhusJeshina Janardhanan, Sherry Joseph Martin, Elisabeth Astrup, et al.
The Journal of Biological Chemistry|March 8, 2022
Structural and biophysical characterization of transcription factor HNF-1A as a tool to study MODY3 diabetes variantsLaura Kind, Arne Raasakka, Janne Molnes, et al.
Transplantation|July 2, 2014
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipientsThor Ueland, Halvor Rollag, Anders Hartmann, et al.
The Journal of Nutrition|April 1, 1996
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense systemP M Ueland, M A Mansoor, A B Guttormsen, et al.
The Journal of Infectious Diseases|December 8, 1998
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failureP Aukrust, F Müller, E Lien, et al.
European Journal of Endocrinology|June 23, 2009
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucoseDag Hofsø, Thor Ueland, Helle Hager, et al.
American Heart Journal|August 25, 2009
The prognostic importance of modifiable risk factors after heart transplantationSatish Arora, Pål Aukrust, Arne Andreassen, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
American Heart Journal|November 8, 2002
Effect of thalidomide in patients with chronic heart failureLars Gullestad, Anne Grete Semb, Even Holt, et al.
Diabetes & Vascular Disease Research|January 12, 2012
Activin A and cardiovascular disease in type 2 diabetes mellitusThor Ueland, Pål Aukrust, Svend Aakhus, et al.
Pageof 102

Showing results (311-320 of 1,012) with videos related to

Sort By:
Pageof 102
Journal of Human Genetics|August 30, 2013
Single-nucleotide polymorphisms in Toll-like receptor (TLR)-2, TLR4 and heat shock protein 70 genes and susceptibility to scrub typhusJeshina Janardhanan, Sherry Joseph Martin, Elisabeth Astrup, et al.
The Journal of Biological Chemistry|March 8, 2022
Structural and biophysical characterization of transcription factor HNF-1A as a tool to study MODY3 diabetes variantsLaura Kind, Arne Raasakka, Janne Molnes, et al.
Transplantation|July 2, 2014
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipientsThor Ueland, Halvor Rollag, Anders Hartmann, et al.
The Journal of Nutrition|April 1, 1996
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense systemP M Ueland, M A Mansoor, A B Guttormsen, et al.
The Journal of Infectious Diseases|December 8, 1998
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failureP Aukrust, F Müller, E Lien, et al.
European Journal of Endocrinology|June 23, 2009
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucoseDag Hofsø, Thor Ueland, Helle Hager, et al.
American Heart Journal|August 25, 2009
The prognostic importance of modifiable risk factors after heart transplantationSatish Arora, Pål Aukrust, Arne Andreassen, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
American Heart Journal|November 8, 2002
Effect of thalidomide in patients with chronic heart failureLars Gullestad, Anne Grete Semb, Even Holt, et al.
Diabetes & Vascular Disease Research|January 12, 2012
Activin A and cardiovascular disease in type 2 diabetes mellitusThor Ueland, Pål Aukrust, Svend Aakhus, et al.
Pageof 102